RespiQ empowers people to take control of their wellbeing through early detection of health issues.

Founded in 2019 by focused, passionate and experienced health tech professionals, RespiQ is developing proven technology that provides accurate, cost-effective health testing at home. 


Our mission is to positively impact the health of millions by providing accurate, non-invasive and affordable technology for early detection of health issues, breath by breath.

Our Team

 
 

Mira Gleisberg
CEO & cofounder

Healthcare expert (Philips)

Strategy consultant (McKinsey)

I am passionate about helping people to take control of their health and improve their overall wellbeing.


 

Cristian D’Alessandro, PhD
CTO

dedicated medical device professional

I am excited about contributing to the development of life-changing medical devices that improve patient outcomes.


 

Jantine Mens
COO/CMO

International MedTech Marketer

Strategic marketing & New Product Launch expert

My drive is to advance the world of health so people can get the care they need to live healthier lives. 

 

Bart Kootte
R&D Engineer

Biomedical & Electrical Engineer

I have always been interested in biomedical applications of electrical engineering.

 

Satadal Dutta, PhD
R&D Scientist

Research-driven Expert in semiconductor device physics, and optoelectronics, With a passion to make science and technology comprehensible for every human being.

 

Trang Anh Nguyen Le, PhD
MEMs & Microfabrication

Biomedical Engineer with an orientation on Nanotechnology.


Advisors & Partners

 

Prof. Han Gardeniers
Advisor

Professor at University of Twente, Faculty of Science and Technology, Mesoscale Chemical Systems

My general research interest is in micro and nanofabrication, applicable in the fields of chemistry and sustainable.

Prof. Mona Bafadhel
Advisor

Chair of Respiratory Medicine at King’s College London

Clinical Academic researcher with a PhD in Biomarkers of exacerbations of Chronic Obstructive Pulmonary Disease (COPD).

Mona is an international academic leader in respiratory medicine, with a passion for translating science to clinical practice to improve patients outcomes. Her work in COPD and COVID-19 has translated to changing clinical practice affecting millions across the world.

Sarah van Hellenberg Hubar-Fisher
Strategic Advisor

New Business Development & Innovation Leader with 21 years of experience in strategic healthcare . 

Advancing the fields of MedTech, HealthTech, and Global Public Health. With a proven track record in creating and executing new ventures, investments, innovation leadership and strategies, deal making and impact capital solutions across global markets.   

Prof. Anke-Hilse Maitland-van der Zee
partner P4O2 & Eurostars

Professor Precision Medicine in Pulmonary disease

Enthusiastic researcher with the main aim of bringing precision medicine to clinical practice. By using biomarkers instead of old fashioned diagnostic labels, goal is to optimise treatment for each individual patient with (respiratory) disease.

Anke-Hilse is leading a team of more than 40 researchers at the department of pulmonary disease in the Amsterdam UMC.

 

Prof. Paul Maguire
Advisor

Professor of Plasmas and Nanofabrication within the School of Engineering at Ulster University. 

With a main research focus on the science and engineering of microplasmas at atmospheric pressure with particular interest in novel applications. 

 

Vitalii Vorkov, PhD
Advisor & cofounder

Full stack mechanical engineer & RespiQ technology inventor

I believe that innovation is a synonym of success and at RespiQ I am in the right place to bring advanced health solutions to society.

 

Philip Siberg
Advisor

Serial entrepreneur with extra focus on medical technology and life science tech.

Founder of Coala Life heart monitor.

Brought 6 medical devices to market.

 
 
 
 
 

Diagnosing and monitoring health issue requires specific tests. These test are often invasive and time consuming. To make health testing more patient focused and accessible, we are developing a breath testing device that will be able to identify several health issues. The respiQ breathalyser allows for testing at home as well as point of care. This will empower individuals take control of their own wellbeing and will help specialist to manage their patients from a distance and intervene if necessary.

Our non-invasive hand-held device measures disease biomarkers in the breath to identify health issues. Our users will receive personalized health insights via our intuitive app. Our proprietary algorithm creates and analyses their digital breathprint, so people can continuously monitor changes to improve their health and wellbeing

This field is developing fast, and we plan to expand as we find opportunities that present the right combination of research maturity and social impact. Clinical research into breath diagnostics is currently showing promising results in detecting disease biomarkers, for illnesses including chronic respiratory disease, cancer and diabetes.